Home
Products
Learn
About
Pricing
Log In
EINC
Asset Logo

🇦🇺 ASX

Compare
Add to watchlist
👑 Overview

📈 Performance

📙 Holdings

💰 Distributions

💵 Cost

🍃 Esg

🤓 Advanced

👨‍👩‍👧‍👦 Community

📈

N/A
Annual Growth

5 years average annual capital growth

💰

5.43%
Annual distribution yield

Based on the most recent distribution

💵

$ 500
Minimum Order

Due to regulatory requirements

🌏

1
Pearlers Invested

Since January 2020

👑 Overview

Key information
🔎 Fund Overview

EINC.AX was created on 2018-02-13 by BetaShares. The fund's investment portfolio concentrates primarily on total market equity. The Fund aims to provide an after-tax income yield above the S&P/ASX 200 Index and to grow this income above the rate of inflation

🌐 Website

📈 Performance

Price History

+1.23%

1M

All Time

Graph

Table

Unsure how much or often to invest?
🗓️ Investing frequency calculator

Determine the investment frequency needed to reach your goals

Try it out →
💵 Investing amount calculator

Determine the recurring investment needed to reach your goals

Try it out →
⏱️ Investing duration calculator

Determine how long you will need to invest to reach your goals

Try it out →

📙 Top Holdings

Show more

Top holdings information is not yet available for this fund. For more information please visit the fund manager's website.

💰 Distributions

Payouts

💰 Annual Distribution Yield*

5.43%

💰 Annual Distribution Earnings Per $1,000 invested**

$54.32

💰 Most Recent Distribution Franked Percentage Estimate

83.98%

💰 Average Distribution Franked Percentage Estimate

87.45 %

💰 Distribution reinvestment

Learn more

* Based on the most recent distribution

** Calculated by multiplying the most recent distribution yield by $1,000

Distribution History

1Y

5Y

10Y

Graph

Table

Year
Yearly Distribution Earnings Per Share
Franking Estimate

2025

$0.00

0.00%

2024

$0.00

0.00%

2023

$0.16

83.98%

2022

$0.54

23.50%

2021

$0.33

24.18%

2020

$0.25

26.95%

2019

$0.37

25.88%

2018

$0.17

40.63%

2017

$0.00

0.00%

2016

$0.00

0.00%

💵 Costs

💵

6.50 AUD*
Purchase Fee

*$5.50 with Pearler Prepay

💼

0.85%
Management Fee

Included in unit price, not charged by Pearler

💸

Want to know the long term costs?
Calculate the historic long term costs to hold your investments
💸 Net fee calculator

🤓 Advanced information

Technical Info

💰 Price*

$8.24

💰 Price To Earnings Ratio

0.00

💰 Price To Book Ratio

0.00

💰 Leveraged

No

💰 Inverse

No

*Price may be up to 24 hours old

👩‍👩‍👦 Community Insights

How our community is investing

🌏 Pearlers invested in EINC

1

📊 Total Capital Earnings

N/A

🔃 Average investment frequency

N/A

💵 Average investment amount

N/A

Last time a customer invested in EINC

709 days
EINC investor breakdown
💵 Income of investors

More than 200k

150k - 200k

100k - 150k

50k - 100k

100%

Less than 50k

👶 Age of investors

18 - 25

26 - 34

100%

35 - 90

🙋 Legal gender of investors

Female

Male

100%

Pearlers who invest in EINC also invest in...

A200

A200.AX was created on 2018-05-07 by BetaShares. The fund's investment portfolio concentrates primarily on large cap equity. The ETF currently has 2975.21m in AUM and 200 holdings. A200.AX aims to track the performance of an index (before fees and expenses) comprising 200 of the largest companies by market capitalisation listed on the ASX.

📊 Share price

$120.79 AUD

NULL AUSTRALIA

NULL BETA

Find Out More

VGS.AX was created on 2014-11-18 by Vanguard. The fund's investment portfolio concentrates primarily on total market equity. Vanguard MSCI International Shares Index ETF seeks to track the return of the MSCI World ex-Australia Index (with net dividends reinvested) in Australian dollars before taking into account fees, expenses and tax.

📊 Share price

$104.08 AUD

NULL GLOBAL

NULL EX AUSTRALIA

NULL BETA

ASIA

ASIA.AX was created on 2018-09-18 by BetaShares. The fund's investment portfolio concentrates primarily on information technology equity. The investment objective of the BetaShares Asia Technology Tigers ETF is to provide an investment return that aims to track the performance of the Solactive Asia ex-Japan Technology & Internet Tigers Index (the Index), before taking into account fees and expenses.

📊 Share price

$7.28 AUD

NULL ASIA

ETHI

ETHI.AX was created on 2017-01-05 by BetaShares. The fund's investment portfolio concentrates primarily on total market equity. The fund aims to track the performance of an index (before fees and expenses) that includes a portfolio of large global stocks identified as Climate Leaders that have also passed screens to exclude companies with direct or significant exposure to fossil fuels or engaged in activities deemed inconsistent with responsible investment considerations.

📊 Share price

$12.45 AUD

NULL GLOBAL

NULL SMART BETA

NULL ETHICAL

NULL EX AUSTRALIA

VTS.AX was created on 2009-05-12 by Vanguard. The fund's investment portfolio concentrates primarily on total market equity. Vanguard U.S. Total Market Shares Index ETF seeks to track the performance of the CRSP US Total Market Index, providing investors with exposure to a broadly diversified collection of securities that, in the aggregate, approximates the full index in terms of key characteristics.

📊 Share price

$320.13 AUD

NULL US

NULL EX AUSTRALIA

NULL BETA

Want more shares? Try these...

EchoIQ Ltd. engages in the development, marketing and commercialization of software, products and services. The company is headquartered in Sydney, New South Wales. The company went IPO on 2010-12-17. The firm is engaged in the product development, marketing and commercialization of software products and services. The company provides cardiac diagnostics technology. The firm has developed cloud-based decision-support software, EchoSolv, powered by artificial intelligence (AI) and machine learning, which aims to provide physicians with a reliable tool to identify patients at-risk of structural heart disease. ECHOiQ’s technology uses AI assisted diagnostics to deliver real-world health solutions. Its screening program uses an AI backed system and access to cardiac big data that identifies patients at risk from aortic stenosis and other forms of structural heart disease. The firm's technology addresses aortic stenosis, heart failure, and mitral and tricuspid regurgitation

📊 Share price

$0.15 AUD
Compare
Add to watchlist